Profil Penggunaan Terapi Pencegahan Sekunder Pada Pasien Stroke Iskemik
MetadataShow full item record
Individuals who survive from the first ischemic stroke are at high risk of recurrent stroke, therefore, they need therapy to prevent the recurrent stroke. America Hearth Association and Indonesian guidelines recommend continued use of antiplatelet, antihypertensive, and lipid lowering therapy after ischemic stroke to reduce the risk of recurrent stroke. The purpose of this study is to know the profil of use antiplatelet, antihypertensive, and lipid lowering therapy in ischemic stroke patient. This research was conducted with a retrospective observational study of patients who were hospitalized with ischemic stroke and collected data came from medical record patients. the Data are served in percentage of use antiplatelet, antihypertensive, and lipid lowering therapy. The number patients’ medical record that have been observed were 165. The use of antiplatelet therapy, about 69% patients received antiplatelet and 31% patients did not receive its medicine, whereas use of antihypertensive, approximately 76% were given and 24% without antihypertensive. Furthermore, 44% of patients were given lipid lowering therapy and 56% no lipid lowering therapy. The proportion of patients dispensed all three recommended medicine classes was 33%.